Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
  • Issues
    • Current
    • Archives
  • Journal Policies
    • Privacy Statement
    • Publication Ethics and Malpractice Statement
    • Artificial Intelligence (AI) Policy
    • Peer Review Process & Policy
    • Open access Policy
    • Archiving
  • For Authors
    • Submissions
    • Author Guidelines
    • Article Processing Charge (APC)
  • Reviewers Guide
  • Announcements
  • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 5 No. Supplement 1 (2012): Supplement 1 -Winter
  4. Original Article

Vol. 5 No. Supplement 1 (2012)

March 2012

Using statistical models to assess medical cost of hepatitis C virus

  • Mohsen Vahedi
  • Asma Pourhoseingholi
  • Sara Ashtari
  • Mohamad Amin Pourhoseingholi
  • Maryam Karkhane
  • Bijan Moghimi-Dehkordi
  • Azadeh Safaee
  • Zahra Kimia
  • Seyed Moayed Alavian

Gastroenterology and Hepatology from Bed to Bench, Vol. 5 No. Supplement 1 (2012), 14 March 2012
https://doi.org/10.22037/ghfbb.v5i1.260 Published: 2012-03-14

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Aim: This study compared PR and NB in predicting HCV patient costs. The objective of this study was to predict the direct cost of the HCV patient in Iran.

Background: Hepatitis C virus (HCV) is a common and expensive infectious disease in Iran.

Cost associated with HCV and its complications has not been well characterized. Analysis of cost data is important in providing consistent information to aid budgeting decisions and certain statistical regression models need for prediction mean costs. Poisson regression (PR) and negative binomial regression (NB) are more common in cost prediction study.

Patients and methods: This study designed as a cross-sectional clinic base from 2001 to 2010. First treatment period of each patient bring in study. We evaluated the doctor visiting, drugs, and hospitalization and laboratory tests of patients. Cost per person per one treatment period estimated in purchasing power parity dollars (PPP$). The PR is one of the models from general linear models (GLM) for describing count outcomes. The NB is another model from (GLM) as an alternative to the PR model.

Results: According to Likelihood ratio test NB was found to be more appropriate than PR (P<0.001). Genotype, marriage, medication, and SVR were being significant. Genotype 3 versus 1 decreasing cost while marriage, consuming pegasys and SVR increasing.

Conclusion: choosing best model in cost data is important because of specific feature of this data. After fitting the best model, analyzing and predicting future cost for patient in different situation is possible.

Keywords:
  • Chronic hepatitis C
  • Costs
  • Predictive models
  • Poisson regression
  • Negative binomial regression
  • PDF

How to Cite

Vahedi, M., Pourhoseingholi, A., Ashtari, S., Pourhoseingholi, M. A., Karkhane, M., Moghimi-Dehkordi, B., … Alavian, S. M. (2012). Using statistical models to assess medical cost of hepatitis C virus. Gastroenterology and Hepatology from Bed to Bench, 5(Supplement 1). https://doi.org/10.22037/ghfbb.v5i1.260
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 278 times
  • PDF Downloaded: 165 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

Powered by OJSPlus